Illium Diazepam Injection USP

SECTION 2: Hazards identification

_______________________________________________________________________________________

Hazard statements

This product is classified as: Not classified as hazardous according to the criteria of SW. Not a Dangerous Good according to Dangerous Goods (DG) Code, IATA and IMDG/IMSBC criteria. Not Hazardous – No criteria found.

Precautionary statements

S24/25. Avoid contact with skin and eyes. SUSMP: S4

ADG classification

None allocated. Not a Dangerous Good under the DG Code.

UN Number

None allocated.

Signal word

NONE. Not hazardous

Prevention

P102: Keep out of reach of children. P262: Do not get in eyes, on skin, or on clothing. P281: Use personal protective equipment as required.

Response

P337: If eye irritation persists: seek medical attention P352: Wash with plenty of soap and water P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting P370+P378: Not combustible. Use extinguishing media suited to burning materials

Storage

P403+P435: Sore in a well-ventilated place. Keep cool

Disposal

P501: Dispose of contents and containers as specified on the registered label EMERGENCY OVERVIEW _______________________________________________________________________________________ Physical Description & Colour: Clear yellow liquid Odour: Odourless to slightly aromatic odour

Health hazards

No significant risk factors have been found for this product. This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can sometimes give unexpected and undesired results. Never operate machinery after contact with this product.

Potential health effects

_______________________________________________________________________________________ Diazepam has a range of side-effects that are common to most benzodiazepines. Most common side effects include: Somnolence, Suppression of REM sleep, Impaired motor function, Impaired co-ordination, Impaired balance, Dizziness and nausea. Inhalation: Short Term Exposure: Available data indicates that this product is not harmful. How- ever product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term inhalation Skin Contact: Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. How-ever product may be irritating but is unlikely to cause anything more than mild transient discomfort. Eye Contact: Shor Term Exposure: This product may be irritating to eyes but is unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. However, this product maybe irritating to mucous membranes but is unlikely to cause anything more than transient discomfort. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SW: No significant ingredient is classified as carcinogenic by SW. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: Diazepam is Class 3 – unclassifiable as to carcinogenicity to humans. See the IARC website for further details. A web address has not been provided as addresses frequently change.